IL6 and neoplasm: Depending on their subtype, TAMs can produce either pro-inflammatory cytokines (e.g., IL-1β and IL-6) or anti-inflammatory cytokines (e.g., IL-4 and IL-10), thereby modulating the cytokine profile and shifting the tumor microenvironment toward either tumor suppression or tumor promotion (91).